Informazione:
Errore:
ID
34426
Descrizione
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations; ODM derived from: https://clinicaltrials.gov/show/NCT01287754
collegamento
https://clinicaltrials.gov/show/NCT01287754
Keywords
versioni (1)
- 17/01/19 17/01/19 -
Titolare del copyright
GSK group of companies
Caricato su
17 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Non-Small Cell Lung Cancer NCT01287754
Eligibility Non-Small Cell Lung Cancer NCT01287754
- StudyEvent: Eligibility
Similar models
Eligibility Non-Small Cell Lung Cancer NCT01287754
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
locally advanced or metastatic (stage iii/iv) non-small cell lung cancer with egfr mutations
boolean
ID.3
Item
measurable disease according to recist criteria
boolean
ID.4
Item
ecog performance status 0-2
boolean
ID.5
Item
adequate haematological, renal and liver function
boolean
ID.6
Item
previous chemotherapy or therapy against egfr for metastatic disease
boolean
ID.7
Item
history of another malignancy, except for in situ carcinoma of the cervix, adequately treated basal cell skin carcinoma, or radically treated prostate carcinoma with good prognosis
boolean
ID.8
Item
symptomatic cerebral metastases
boolean
ID.9
Item
pre-existing parenchymal lung disease such as pulmonary fibrosis
boolean
ID.10
Item
concomitant use of coumarins
boolean